Comparison of treatment retention between risperidone long-acting injection, paliperidone palmitate, and aripiprazole once-monthly in elderly patients with schizophrenia

被引：2
|
作者：
Suzuki, Hidenobu [1 ]
Hibino, Hiroyuki [2 ]
机构：
[1] Suzuki Clin, Dept Psychiat, 3-34-16 Hamadayama, Tokyo 1680065, Japan
[2] Univ Tokyo, Dept Neuropsychiat, Tokyo, Japan
来源：
PSYCHOGERIATRICS | 2022年 / 22卷 / 01期
关键词：
D O I：
10.1111/psyg.12784
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：159 / 160
页数：2
相关论文
共 50 条
  • [21] Efficacy and tolerability Aripiprazole once-monthly long-acting injectable in schizophrenia. Two-injection start regimen
    Romero Guillena, S. L.
    Plasencia Garcia De Diego, B. O.
    Gotor Sanchez-Luengo, F.
    Gomez Gonzalez, J.
    EUROPEAN PSYCHIATRY, 2022, 65 : S788 - S789
  • [22] CHANGE IN PROLACTIN AND SEXUAL SIDE EFFECTS IN PATIENTS WITH SCHIZOPHRENIA WHO SWITCHED FROM PALIPERIDONE PALMITATE OR RISPERIDONE LONG-ACTING INJECTION TO ARIPIPRAZOLE LAUROXIL
    Kelly, Deanna
    Claxton, Amy
    Bidollari, Ilda
    Du, Yangchun
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S255 - S255
  • [23] Comparison of Treatment Retention Between Risperidone Long-Acting Injection and First-Generation Long-Acting Injections in Patients With Schizophrenia for 5 Years
    Suzuki, Hidenobu
    Hibino, Hiroyuki
    Inoue, Yuichi
    Takaya, Atsuhiko
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2016, 36 (04) : 405 - 406
  • [24] Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain
    Javier Quintero
    Itziar Oyagüez
    Beatriz González
    Ignacio Cuervo-Arango
    Ignacio García
    Miguel Angel Casado
    Clinical Drug Investigation, 2016, 36 : 479 - 490
  • [25] Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain
    Quintero, Javier
    Oyaguez, Itziar
    Gonzalez, Beatriz
    Cuervo-Arango, Ignacio
    Garcia, Ignacio
    Angel Casado, Miguel
    CLINICAL DRUG INVESTIGATION, 2016, 36 (06) : 479 - 490
  • [26] Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly
    Enrico Biagi
    Enrico Capuzzi
    Fabrizia Colmegna
    Alessandra Mascarini
    Giulia Brambilla
    Alessandra Ornaghi
    Jacopo Santambrogio
    Massimo Clerici
    Advances in Therapy, 2017, 34 : 1036 - 1048
  • [27] Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly
    Biagi, Enrico
    Capuzzi, Enrico
    Colmegna, Fabrizia
    Mascarini, Alessandra
    Brambilla, Giulia
    Ornaghi, Alessandra
    Santambrogio, Jacopo
    Clerici, Massimo
    ADVANCES IN THERAPY, 2017, 34 (05) : 1036 - 1048
  • [28] Paliperidone palmitate long-acting injection in schizophrenic patients
    Suarez Gisbert, E.
    EUROPEAN PSYCHIATRY, 2020, 63 : S540 - S540
  • [29] Once-monthly injection of paliperidone palmitate in patients with recently diagnosed and chronic schizophrenia: a post-hoc comparison of efficacy and safety
    Si, Tianmei
    Zhuo, Jianmin
    Turkoz, Ibrahim
    Mathews, Maju
    Tan, Wilson
    Feng, Yu
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (17) : 1799 - 1809
  • [30] Projecting the Potential Effect of Using Paliperidone Palmitate Once-Monthly and Once-Every-3-Months Long-Acting Injections Among Medicaid Beneficiaries with Schizophrenia
    Basu, Anirban
    Benson, Carmela
    Alphs, Larry
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (08): : 759 - +
12345